Targets a 65% gross margin by 2026.
Plans to launch the Mobi Tubeless device in 2026.
Shifting focus towards pharmacy distribution.
Strategic angle: Tandem Diabetes Care outlines strategic changes aimed at improving profitability and launching innovative products.
Targets a 65% gross margin by 2026.
Plans to launch the Mobi Tubeless device in 2026.
Shifting focus towards pharmacy distribution.